Find out what challenges top the list, and what analysts say can be done about them.
Prepare for major pipeline developments in diabetes, autoimmune disorders, oncology, and COPD.
PBMs partnering with pharmacies and drug makers may have a solution to nonadherence due to high pharma costs.
Polypharmacy presents real problems—especially for older adults.
Despite front-end scrutiny, payers seek audit process to improve high-cost specialty pharmacies.
Part D program exceeds industry expectations
Oncology pathways can lead to quality programs and more cost-effective care for cancer patients.
Physician assistants (PAs) and nurse practitioners (NPs) could solve the shortage of primary care physicians and the rising cost of healthcare.
Retirees can expect to shoulder more than half of the cost burden of health benefits—51% to 54%—according to Towers Watson's 2010 Retiree Health Care Cost Survey.
Generic drugs have certainly made their mark, but don't count on the same savings in the specialty market.